| 17alpha-ethynylestradiol | affects expression | ISO | RGD:1315574 | 6480464 | Ethinyl Estradiol affects the expression of TPD52 mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of TPD52 mRNA | CTD | PMID:17557909 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1315574 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TPD52 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:1315574 | 6480464 | Ethinyl Estradiol results in increased expression of TPD52 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1315574 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TPD52 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TPD52 mRNA | CTD | PMID:20959002 PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1315574 | 6480464 | Tetrachlorodibenzodioxin affects the expression of TPD52 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TPD52 mRNA | CTD | PMID:21215274 |
| 2-nitrofluorene | decreases expression | ISO | RGD:1315573 | 6480464 | 2-nitrofluorene results in decreased expression of TPD52 mRNA | CTD | PMID:21873647 |
| 2-nitrofluorene | increases expression | ISO | RGD:1315573 | 6480464 | 2-nitrofluorene results in increased expression of TPD52 mRNA | CTD | PMID:21873647 |
| 3-methylcholanthrene | increases expression | ISO | RGD:1315574 | 6480464 | Methylcholanthrene results in increased expression of TPD52 mRNA | CTD | PMID:20713471 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | decreases expression | ISO | RGD:1315573 | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of TPD52 mRNA | CTD | PMID:21873647 |
| aflatoxin B1 | decreases expression | ISO | RGD:1315573 | 6480464 | Aflatoxin B1 results in decreased expression of TPD52 mRNA | CTD | PMID:21873647 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1315573 | 6480464 | Benzo(a)pyrene results in decreased expression of TPD52 mRNA | CTD | PMID:21873647 |
| bicalutamide | decreases response to substance | ISO | RGD:1315574 | 6480464 | TPD52 protein results in decreased susceptibility to bicalutamide | CTD | PMID:17875733 |
| choline | multiple interactions | ISO | RGD:1315574 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TPD52 mRNA | CTD | PMID:20938992 |
| clofibrate | increases expression | ISO | RGD:1315574 | 6480464 | Clofibrate results in increased expression of TPD52 mRNA | CTD | PMID:17585979 |
| clonidine | increases expression | ISO | RGD:1315573 | 6480464 | Clonidine results in increased expression of TPD52 mRNA | CTD | PMID:21873647 |
| clonidine (amino form) | increases expression | ISO | RGD:1315573 | 6480464 | Clonidine results in increased expression of TPD52 mRNA | CTD | PMID:21873647 |
| clonidine (imino form) | increases expression | ISO | RGD:1315573 | 6480464 | Clonidine results in increased expression of TPD52 mRNA | CTD | PMID:21873647 |
| copper atom | multiple interactions | ISO | RGD:1315573 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of TPD52 mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | ISO | RGD:1315573 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of TPD52 mRNA | CTD | PMID:20971185 |
| copper(2+) sulfate | increases expression | ISO | RGD:1315573 | 6480464 | Copper Sulfate results in increased expression of TPD52 mRNA | CTD | PMID:19549813 |
| coumestrol | multiple interactions | ISO | RGD:1315573 | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TPD52 mRNA | CTD | PMID:19167446 |
| cyclophosphamide | decreases expression | ISO | RGD:1315573 | 6480464 | Cyclophosphamide results in decreased expression of TPD52 mRNA | CTD | PMID:21873647 |
| D-mannitol | decreases expression | ISO | RGD:1315573 | 6480464 | Mannitol results in decreased expression of TPD52 mRNA | CTD | PMID:21873647 |
| D-mannitol | increases expression | ISO | RGD:1315573 | 6480464 | Mannitol results in increased expression of TPD52 mRNA | CTD | PMID:21873647 |
| Delta(9)-tetrahydrocannabinol | decreases expression | ISO | RGD:1315574 | 6480464 | Tetrahydrocannabinol results in decreased expression of TPD52 mRNA | CTD | PMID:12237329 |
| diarsenic trioxide | increases expression | ISO | RGD:1315573 | 6480464 | arsenic trioxide results in increased expression of TPD52 mRNA | CTD | PMID:20458559 |
| diarsenic trioxide | increases expression | ISO | RGD:1315573 | 6480464 | arsenic trioxide results in increased expression of TPD52 mRNA | CTD | PMID:20458559 PMID:22521957 |
| dibutyl phthalate | decreases expression | ISO | RGD:1315574 | 6480464 | Dibutyl Phthalate results in decreased expression of TPD52 mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | decreases expression | ISO | RGD:1315574 | 6480464 | Dibutyl Phthalate results in decreased expression of TPD52 mRNA | CTD | PMID:17361019 PMID:21266533 |
| diclofenac | increases expression | ISO | RGD:1315573 | 6480464 | Diclofenac results in increased expression of TPD52 mRNA | CTD | PMID:21873647 |
| diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of TPD52 mRNA | CTD | PMID:21551480 |
| folic acid | multiple interactions | ISO | RGD:1315574 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TPD52 mRNA | CTD | PMID:20938992 |
| furan | increases methylation | EXP | | 6480464 | furan results in increased methylation of TPD52 gene | CTD | PMID:22079235 |
| L-methionine | multiple interactions | ISO | RGD:1315574 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TPD52 mRNA | CTD | PMID:20938992 |
| methapyrilene | increases expression | ISO | RGD:1315573 | 6480464 | Methapyrilene results in increased expression of TPD52 mRNA | CTD | PMID:21873647 |
| methapyrilene | decreases expression | ISO | RGD:1315573 | 6480464 | Methapyrilene results in decreased expression of TPD52 mRNA | CTD | PMID:21873647 |
| mitomycin C | affects response to substance | ISO | RGD:1315573 | 6480464 | TPD52 protein affects the susceptibility to Mitomycin | CTD | PMID:16217747 |
| mitoxantrone | affects response to substance | ISO | RGD:1315573 | 6480464 | TPD52 protein affects the susceptibility to Mitoxantrone | CTD | PMID:16217747 |
| nickel sulfate | increases expression | ISO | RGD:1315573 | 6480464 | nickel sulfate results in increased expression of TPD52 mRNA | CTD | PMID:16780908 |
| nifedipine | increases expression | ISO | RGD:1315573 | 6480464 | Nifedipine results in increased expression of TPD52 mRNA | CTD | PMID:21873647 |
| paclitaxel | decreases expression | ISO | RGD:1315573 | 6480464 | Paclitaxel results in decreased expression of TPD52 mRNA | CTD | PMID:19682730 |
| paracetamol | affects expression | ISO | RGD:1315574 | 6480464 | Acetaminophen affects the expression of TPD52 mRNA | CTD | PMID:17562736 |
| phenobarbital | multiple interactions | ISO | RGD:1315574 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of TPD52 mRNA] | CTD | PMID:19482888 |
| phenobarbital | increases expression | ISO | RGD:1315573 | 6480464 | Phenobarbital results in increased expression of TPD52 mRNA | CTD | PMID:21873647 |
| phenobarbital | increases expression | ISO | RGD:1315574 | 6480464 | Phenobarbital results in increased expression of TPD52 mRNA | CTD | PMID:19482888 |
| phorbol 13-acetate 12-myristate | decreases expression | ISO | RGD:1315573 | 6480464 | Tetradecanoylphorbol Acetate results in decreased expression of TPD52 mRNA | CTD | PMID:21873647 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:1315573 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of TPD52 mRNA | CTD | PMID:21873647 |
| piperonyl butoxide | decreases expression | ISO | RGD:1315573 | 6480464 | Piperonyl Butoxide results in decreased expression of TPD52 mRNA | CTD | PMID:21873647 |
| pirinixic acid | decreases expression | ISO | RGD:1315573 | 6480464 | pirinixic acid results in decreased expression of TPD52 mRNA | CTD | PMID:21873647 |
| pirinixic acid | increases expression | ISO | RGD:1315573 | 6480464 | pirinixic acid results in increased expression of TPD52 mRNA | CTD | PMID:21873647 |
| tamoxifen | affects expression | ISO | RGD:1315574 | 6480464 | Tamoxifen affects the expression of TPD52 mRNA | CTD | PMID:17555576 |
| tetrachloromethane | affects expression | ISO | RGD:1315574 | 6480464 | Carbon Tetrachloride affects the expression of TPD52 mRNA | CTD | PMID:17484886 |
| tolbutamide | decreases expression | ISO | RGD:1315573 | 6480464 | Tolbutamide results in decreased expression of TPD52 mRNA | CTD | PMID:21873647 |
| tolbutamide | increases expression | ISO | RGD:1315573 | 6480464 | Tolbutamide results in increased expression of TPD52 mRNA | CTD | PMID:21873647 |
| valproic acid | affects expression | ISO | RGD:1315574 | 6480464 | Valproic Acid affects the expression of TPD52 mRNA | CTD | PMID:17292431 |